|Articles|March 1, 2002
- Applied Clinical Trials-03-01-2002
Selecting Sites and Investigators
The system is an important part of the selection equation in CEE nations where sponsors must contract with institutions rather than investigators. Examples from Hungary offer guidelines for improving selection SOPs.
Advertisement
Articles in this issue
over 23 years ago
Consider Geography When Choosing Investigative Sitesover 23 years ago
Meet the Editorial Advisory Board Francis Crawleyover 23 years ago
9th ACT European Summitover 23 years ago
Letters to the Editorover 23 years ago
Safety and Risk Assessment Gain Importanceover 23 years ago
Transporting Clinical Trial Samplesover 23 years ago
Forward to 2004 or Back to 1984?Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
2
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
